News

Check Out the Latest News and Activities at Ambys

Press Releases

06.27.2022
Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards with Leading Liver Disease and Cell and Gene Therapy Experts
Read More
06.09.2022
Ambys Medicines to Present Data from Universal Human Hepatocyte Program at the 2022 ISSCR Annual Meeting
Read More

Social Media

Events & Features

05.18.2022
Ambys Presents New Data Further Validating its Novel Liver Cell Replacement Therapy Platform Read More
05.18.2022
Genetically Engineered Hypoimmune Hepatocytes Can Rescue Disease – Presentation at ASGCT 2022 View Slides
05.17.2022
Ambys Medicines: We are Ambytious Read More
05.17.2022
Human Hepatocytes Expanded in a Novel Rat Bioreactor Maintain Full Functionality In Vitro and In Vivo – Poster View Poster
05.15.2022
Ex Vivo Genetically Engineered Hyperfunctional Primary Human Hepatocytes can Produce Clinically-Relevant Levels of Therapeutic Factor IX In Vivo – Poster View Poster
09.25.2021
Development of a novel in vivo bioreactor system to manufacture human hepatocyte cell therapies – Oral Presentation at IXA-CTRMS Read More

Archived ‘Liver Spotlight Series’ Webinars

In this free, three-part educational series, Ambys is featuring presentations from leading academic liver disease researchers, exploring advances in the understanding of liver biology and new frontiers in liver disease therapeutics.
Play archived presentation
Play archived presentation
Play archived presentation
Top